Offices:
Vantaa
Investors:
we tracked 7 investors
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Total investments received (USD) - we tracked 5 transactions
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Nightingale Health, formerly Brainshake Ltd., is a science-based blood testing company bringing extensive biological data to routine healthcare. The technology aims is to replace reactive healthcare and enable preventive medicine in chronic diseases.
The company registered 1.6 million euros in revenue in 2015
Companies with similar profile to Nightingale Health:
| Company | Criteria |
|---|
 Glucostratus (Mendor)53% | - Similar verticals: Health services
- Similar business models: B2B
- At least one other investor: Finnvera
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Synoste Oy 53% | - Similar verticals: Health services
- Similar business models: B2B
- At least one other investor: Business Finland, Finnvera
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Blueprint Genetics 53% | - Similar verticals: Health services
- Similar business models: B2B
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Forendo Pharma 53% | - Similar verticals: Health services
- Similar business models: B2B
- At least one other investor: Finnvera
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Oura Health 53% | - Similar verticals: Health services
- Similar business models: B2B
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
 Irras43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
 AFYX Therapeutics43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| NMD Pharma 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Aprea Therapeutics 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| AMRA 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Liva Healthcare 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| TILT Biotherapeutics 43% | - Similar verticals: Health services
- Similar business models: B2B
- At least one other investor: Business Finland
- Total raised in a similar range: 10M+ USD
|
 Alvotech43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Galecto Biotech 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| STipe Therapeutics 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| BC Platforms 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Modus Therapeutics 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Unibio 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Asarina Pharma 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Valkee 43% | - Similar verticals: Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
